Sort   by:  
 Page size 
UnknownPhase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors.
Not available
S-EPMC6510847 | biostudies-literature
UnknownRole of schools in disaster risk management: a systematic review.
Not available
S-EPMC12822327 | biostudies-literature
UnknownGenomic analyses of high-grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities.
Not available
S-EPMC8637558 | biostudies-literature
UnknownPreparedness dimensions and components of emergency medical services in chemical hazards: a systematic review.
Not available
S-EPMC11827237 | biostudies-literature
UnknownEfficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
Not available
S-EPMC5857389 | biostudies-literature
UnknownImmunotherapy in EGFR mutant non-small cell lung cancer: when, who and how?
Not available
S-EPMC6835106 | biostudies-literature
UnknownRICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR.
Not available
S-EPMC5351607 | biostudies-literature
UnknownDressings combined with injection of meglumine antimoniate in the treatment of cutaneous leishmaniasis: a randomized controlled clinical trial.
Not available
S-EPMC3691234 | biostudies-literature
UnknownRandomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.
Not available
S-EPMC6085179 | biostudies-literature
UnknownComparison of power between randomized discontinuation design and upfront randomization design on progression-free survival.
Not available
S-EPMC2734425 | biostudies-literature
Sort   by:  
 Page size